Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive review of Bcl‐2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small molecules

28 Feb 2024

Abstract excerpt

Cancer has a considerably higher fatality rate than other diseases globally and is one of the most lethal and profoundly disruptive ailments. The increasing incidence of cancer among humans is one of the greatest challenges in the field of healthcare. A significant factor in the initiation and progression of tumorigenesis is the dysregulation of physiological processes governing cell death, which results in the...

Topics

Join the communities discussing this publication.

Cancer-related Molecular Pathways
Cell death mechanisms and regulation
Retinoids in leukemia and cellular processes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38415799
DOI: 10.1002/ptr.8157

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive review of Bcl‐2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small moleculesPMID 38415799Read ↗

Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancerSemantic proximity Read ↗

Targeting Bcl-2 Family Proteins: What, Where, When?Semantic proximity Read ↗

B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer TherapySemantic proximity Read ↗

Modulating the Bcl-2 Family of Apoptosis Suppressors for Potential Therapeutic Benefit in CancerSemantic proximity Read ↗

Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancerSemantic proximity Read ↗

Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?Semantic proximity Read ↗

BCL-2 family isoforms in apoptosis and cancerSemantic proximity Read ↗

Emerging Biomarkers and Potential Therapeutics of the BCL-2 Protein Family: The Apoptotic and Anti-Apoptotic ContextSemantic proximity Read ↗

Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent reviewSemantic proximity Read ↗

Regulation of Apoptosis by the Bcl-2 Family of Proteins: Field on a BrinkSemantic proximity Read ↗

The Bcl-2-regulated apoptotic pathwaySemantic proximity Read ↗

Attacking cancer's Achilles heel: antagonism of anti‐apoptotic <scp>BCL</scp>‐2 family membersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.